Adalta Capital Management’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $10.7M | Sell |
88,591
-989
| -1% | -$114K | 5.13% | 4 |
|
|
2025
Q4 | $9.51M | Sell |
89,580
-600
| -0.7% | -$56.3K | 4.24% | 8 |
|
|
2025
Q3 | $7.64M | Hold |
90,180
| – | – | 3.47% | 11 |
|
|
2025
Q2 | $7.21M | Buy |
90,180
+19
| +0% | +$1.51K | 3.62% | 11 |
|
|
2025
Q1 | $8.17M | Buy |
90,161
+36
| +0% | +$3.36K | 4.35% | 8 |
|
|
2024
Q4 | $9.04M | Hold |
90,125
| – | – | 4.72% | 6 |
|
|
2024
Q3 | $10.3M | Sell |
90,125
-58
| -0.1% | -$6.89K | 5.31% | 5 |
|
|
2024
Q2 | $11.2M | Sell |
90,183
-77
| -0.1% | -$9.92K | 6.11% | 3 |
|
|
2024
Q1 | $12M | Buy |
90,260
+1,180
| +1% | +$145K | 6.62% | 2 |
|
|
2023
Q4 | $9.78M | Sell |
89,080
-120
| -0.1% | -$12.5K | 5.91% | 4 |
|
|
2023
Q3 | $9.25M | Buy |
89,200
+156
| +0.2% | +$16.8K | 6.3% | 3 |
|
|
2023
Q2 | $10.3M | Hold |
89,044
| – | – | 6.91% | 2 |
|
|
2023
Q1 | $9.54M | Buy |
89,044
+34
| +0% | +$3.67K | 6.67% | 2 |
|
|
2022
Q4 | $9.94M | Sell |
89,010
-200
| -0.2% | -$20.4K | 7.01% | 2 |
|
|
2022
Q3 | $7.74M | Hold |
89,210
| – | – | 5.56% | 4 |
|
|
2022
Q2 | $8.19M | Sell |
89,210
-25
| -0% | -$2.22K | 5.32% | 4 |
|
|
2022
Q1 | $7.38M | Hold |
89,235
| – | – | 3.68% | 9 |
|
|
2021
Q4 | $6.89M | Buy |
89,235
+13,125
| +17% | +$1.05M | 3.18% | 10 |
|
|
2021
Q3 | $5.77M | Sell |
76,110
-40
| -0.1% | -$3.04K | 3.19% | 11 |
|
|
2021
Q2 | $5.97M | Sell |
76,150
-3,603
| -5% | -$268K | 3.25% | 12 |
|
|
2021
Q1 | $5.92M | Sell |
79,753
-969
| -1% | -$71.5K | 3.41% | 11 |
|
|
2020
Q4 | $6.35M | Buy |
80,722
+393
| +0.5% | +$30.1K | 4.01% | 8 |
|
|
2020
Q3 | $6.41M | Buy |
80,329
+78
| +0.1% | +$6.11K | 4.67% | 5 |
|
|
2020
Q2 | $5.97M | Sell |
80,251
-660
| -0.8% | -$49.7K | 4.75% | 5 |
|
|
2020
Q1 | $5.99M | Sell |
80,911
-2,688
| -3% | -$211K | 5.44% | 3 |
|
|
2019
Q4 | $7.3M | Sell |
83,599
-524
| -0.6% | -$43K | 4.6% | 4 |
|
|
2019
Q3 | $6.8M | Buy |
84,123
+131
| +0.2% | +$10.5K | 4.51% | 4 |
|
|
2019
Q2 | $6.76M | Buy |
83,992
+4,244
| +5% | +$325K | 4.45% | 4 |
|
|
2019
Q1 | $6.37M | Buy |
79,748
+944
| +1% | +$70.6K | 4.82% | 3 |
|
|
2018
Q4 | $5.79M | Sell |
78,804
-1,048
| -1% | -$74K | 5.41% | 3 |
|
|
2018
Q3 | $5.44M | Hold |
79,852
| – | – | 3.88% | 4 |
|
|
2018
Q2 | $4.66M | Sell |
79,852
-289
| -0.4% | -$16.3K | 3.29% | 7 |
|
|
2018
Q1 | $4.2M | Buy |
80,141
+110
| +0.1% | +$5.94K | 3.21% | 9 |
|
|
2017
Q4 | $4.33M | Sell |
80,031
-1,886
| -2% | -$105K | 3.3% | 8 |
|
|
2017
Q3 | $5.04M | Sell |
81,917
-629
| -0.8% | -$38.1K | 4.12% | 5 |
|
|
2017
Q2 | $5.08M | Buy |
82,546
+3,249
| +4% | +$198K | 4.1% | 5 |
|
|
2017
Q1 | $4.84M | Buy |
+79,297
| New | +$4.81M | 4.1% | 3 |
|
Other funds holding MRK
VCM
VPM
Adalta Capital Management's MRK Position: Q1 2026 in Review
Adalta Capital Management reduced its Merck (MRK) stake by 1.1% in Q1 2026, selling an estimated $114K and leaving 88,591 shares worth $10.7M. The position accounts for 5.13% of the portfolio, ranked #4.
Adalta Capital Management first reported a position in MRK in Q1 2017 and has held it in 37 quarters since. The position peaked at $12M in Q1 2024. 3,779 funds tracked by Wall St. Rank hold MRK as of Q1 2026.
- Adalta Capital Management held 88,591 shares of Merck worth $10.7M as of Q1 2026.
- Adalta Capital Management sold 989 Merck shares in Q1 2026, an estimated $114K.
- Merck made up 5.13% of Adalta Capital Management's portfolio in Q1 2026, its #4 holding.
- Adalta Capital Management first reported a position in Merck in Q1 2017 and has held it in 37 quarters since.
- Adalta Capital Management's Merck position peaked at $12M in Q1 2024.
- 3,779 funds tracked by Wall St. Rank held Merck as of Q1 2026.
Based on Adalta Capital Management's 13F filing for Q1 2026, filed 18 May 2026.